These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2473749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of ribonucleolytic activity of angiogenin towards tRNA.
    Lee FS, Vallee BL.
    Biochem Biophys Res Commun; 1989 May 30; 161(1):121-6. PubMed ID: 2730651
    [Abstract] [Full Text] [Related]

  • 4. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.
    Shapiro R, Vallee BL.
    Biochemistry; 1989 Sep 05; 28(18):7401-8. PubMed ID: 2479414
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
    Newton DL, Xue Y, Olson KA, Fett JW, Rybak SM.
    Biochemistry; 1996 Jan 16; 35(2):545-53. PubMed ID: 8555226
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-angiogenin activity of the peptides complementary to the receptor-binding site of angiogenin.
    Gho YS, Chae CB.
    J Biol Chem; 1997 Sep 26; 272(39):24294-9. PubMed ID: 9305884
    [Abstract] [Full Text] [Related]

  • 9. Enzymatically active angiogenin/ribonuclease A hybrids formed by peptide interchange.
    Harper JW, Auld DS, Riordan JF, Vallee BL.
    Biochemistry; 1988 Jan 12; 27(1):219-26. PubMed ID: 3349027
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells.
    Jimi S, Ito K, Kohno K, Ono M, Kuwano M, Itagaki Y, Ishikawa H.
    Biochem Biophys Res Commun; 1995 Jun 15; 211(2):476-83. PubMed ID: 7540839
    [Abstract] [Full Text] [Related]

  • 13. Mutagenesis of residues flanking Lys-40 enhances the enzymatic activity and reduces the angiogenic potency of angiogenin.
    Harper JW, Fox EA, Shapiro R, Vallee BL.
    Biochemistry; 1990 Aug 07; 29(31):7297-302. PubMed ID: 1698454
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.
    Lee FS, Shapiro R, Vallee BL.
    Biochemistry; 1989 Jan 10; 28(1):225-30. PubMed ID: 2706246
    [Abstract] [Full Text] [Related]

  • 16. Replacement of residues 8-22 of angiogenin with 7-21 of RNase A selectively affects protein synthesis inhibition and angiogenesis.
    Bond MD, Vallee BL.
    Biochemistry; 1990 Apr 03; 29(13):3341-9. PubMed ID: 1692238
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A monoclonal antibody to human angiogenin. Inhibition of ribonucleolytic and angiogenic activities and localization of the antigenic epitope.
    Fett JW, Olson KA, Rybak SM.
    Biochemistry; 1994 May 10; 33(18):5421-7. PubMed ID: 7514035
    [Abstract] [Full Text] [Related]

  • 19. Dual site model for the organogenic activity of angiogenin.
    Hallahan TW, Shapiro R, Vallee BL.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2222-6. PubMed ID: 2006161
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.